Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 9049-9056
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9049
Figure 1
Figure 1 Serum Insulin-like growth factor-binding protein 5 concentrations in Crohn’s disease patients and healthy controls. Serum insulin-like growth factor-binding protein 5 (IGFBP-5) (ELISA) levels were significantly decreased in patients with Crohn’s disease compared to healthy controls (P < 0.001). P value from Mann-Whitney test.